6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Scinai Immunotherapeutics Ltd.
Filed: May 18, 2022
Period of Report: May 18, 2022
Accession Number: 0001213900-22-027802

View Document ↗ View on SEC.gov ↗